First Long-Term Outcome Data for the MicraVR™ Transcatheter Pacing System: Data from the Largest Prospective German Cohort

Arian Sultan,Cornelia Scheurlen,Jonas Wörmann,Jan-Hendrik van den Bruck,Karlo Filipovic,Susanne Erlhöfer,Sebastian Dittrich,Jan-Hendrik Schipper,Jakob Lüker,Jan-Malte Sinning,Dinh Quang Nguyen, Sören Fischer,Daniel Steven,Stefan Winter

Clinical research in cardiology（2023）

引用 1|浏览11

暂无评分

摘要

The MicraVR™ transcatheter pacing system (TPS) has been implemented into clinical routine for several years. The primary recipients are patients in need for VVI pacing due to bradycardia in the setting of atrial fibrillation (AF). Implantation safety and acute success have been proven in controlled studies and registries. So far only few long-term real-life data on TPS exist. We report indication, procedure and outcome data from two high-volume implanting German centers. Between 2016 and 2019, 188 (of 303) patients were included. During follow-up (FU), TPS interrogation was performed after 4 weeks and thereafter every 6 months. Indication for TPS implantation in 159/188 (85

查看译文

关键词

Leadless pacer,Outside registry experience,Long-term follow-up,Indications,Complications

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要